Literature DB >> 26049759

The role of aberrant proteolysis in lymphomagenesis.

Anagh A Sahasrabuddhe1, Kojo S J Elenitoba-Johnson.   

Abstract

PURPOSE OF REVIEW: Deregulated proteolysis is increasingly being implicated in pathogenesis of lymphoma. In this review, we highlight the major cellular processes that are affected by deregulated proteolysis of critical substrates that promote lymphoproliferative disorders. RECENT
FINDINGS: Emerging evidence supports the role of aberrant proteolysis by the ubiquitin proteasome system (UPS) in lymphoproliferative disorders. Several UPS mediators are identified to be altered in lymphomagenesis. However, the precise role of their alteration and comprehensive knowledge of their target substrate critical for lymphomagenesis is far from complete.
SUMMARY: Many E3 ligase and deubiquitinases that contribute to regulated proteolysis of substrates critical for major cellular processes are altered in various lineages of lymphoma. Understanding of the proteolytic regulatory mechanisms of these major cellular pathways may offer novel biomarkers and targets for lymphoma therapy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26049759      PMCID: PMC4459522          DOI: 10.1097/MOH.0000000000000156

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  155 in total

1.  Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.

Authors:  Masayoshi Yada; Shigetsugu Hatakeyama; Takumi Kamura; Masaaki Nishiyama; Ryosuke Tsunematsu; Hiroyuki Imaki; Noriko Ishida; Fumihiko Okumura; Keiko Nakayama; Keiichi I Nakayama
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

2.  Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma.

Authors:  D De Jong; B M Voetdijk; G C Beverstock; G J van Ommen; R Willemze; P M Kluin
Journal:  N Engl J Med       Date:  1988-05-26       Impact factor: 91.245

Review 3.  The ubiquitous nature of cancer: the role of the SCF(Fbw7) complex in development and transformation.

Authors:  K M Crusio; B King; L B Reavie; I Aifantis
Journal:  Oncogene       Date:  2010-06-14       Impact factor: 9.867

4.  Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7).

Authors:  Anders Sundqvist; Maria T Bengoechea-Alonso; Xin Ye; Vasyl Lukiyanchuk; Jianping Jin; J Wade Harper; Johan Ericsson
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

5.  TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.

Authors:  Keiichiro Honma; Shinobu Tsuzuki; Masao Nakagawa; Hiroyuki Tagawa; Shigeo Nakamura; Yasuo Morishima; Masao Seto
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

6.  Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation.

Authors:  Chainarong Tunyaplin; A L Shaffer; Cristina D Angelin-Duclos; Xin Yu; Louis M Staudt; Kathryn L Calame
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

7.  Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells.

Authors:  M Pettersson; H Jernberg-Wiklund; L G Larsson; C Sundström; I Givol; Y Tsujimoto; K Nilsson
Journal:  Blood       Date:  1992-01-15       Impact factor: 22.113

Review 8.  Targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?

Authors:  K Brinkmann; H Kashkar
Journal:  Cell Death Dis       Date:  2014-03-06       Impact factor: 8.469

9.  βTrCP controls the lysosome-mediated degradation of CDK1, whose accumulation correlates with tumor malignancy.

Authors:  Joaquín Herrero-Ruiz; Mar Mora-Santos; Servando Giráldez; Carmen Sáez; Miguel A Japón; Maria Tortolero; Francisco Romero
Journal:  Oncotarget       Date:  2014-09-15

10.  Mcl-1 ubiquitination: unique regulation of an essential survival protein.

Authors:  Barbara Mojsa; Iréna Lassot; Solange Desagher
Journal:  Cells       Date:  2014-05-08       Impact factor: 6.600

View more
  2 in total

1.  LBD: a manually curated database of experimentally validated lymphoma biomarkers.

Authors:  Bin Tan; Saige Xin; Yanshi Hu; Cong Feng; Ming Chen
Journal:  Database (Oxford)       Date:  2022-07-05       Impact factor: 4.462

2.  Loss of Setd4 delays radiation-induced thymic lymphoma in mice.

Authors:  Xing Feng; Huimei Lu; Jingyin Yue; Neta Schneider; Jingmei Liu; Lisa K Denzin; Chang S Chan; Subhajyoti De; Zhiyuan Shen
Journal:  DNA Repair (Amst)       Date:  2019-11-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.